Skip to main content

November 2013

Before You Collaborate, You Should Partner with NCI TTC

As the fall and winter seasons progress, you may be attending more scientific conferences, where you may find a number of opportunities for research collaborations. To assist your lab in reaching its research goals through collaborations, the staff of the National Cancer Institute Technology Transfer Center can guide you through a tool box of agreements you may need for protecting your intellectual property and effectively managing your collaboration.

Getting the Picture

Recently, I attended the annual meeting of the BioCommunications Association in Asilomar, Calif. Not surprisingly, the speakers, all professional communicators, were very good and spoke knowledgeably on their various topics. But something else impressed me during the informal times between presentations, and at mealtimes. These folks not only tended to speak well, but they also tended to listen well. And there’s a very strong case to be made for the importance of listening in effective communication.

Is This Your Year to Inspire a Child?

The Elementary Outreach Program (EOP) is looking for volunteers for the 2013–2014 school year. This program is designed to bring science into the classrooms of Frederick County students in grades 1 through 5. You’ll have a chance to work with small groups of children, presenting hands-on lessons that are coordinated with the school curriculum. Volunteer teams in each grade are scheduled to visit four schools in Frederick County this year.

Novel Vaccine Approach Achieves “Functional Cure” of AIDS Virus in Monkeys

Scientists at the Oregon Health & Science University and the AIDS and Cancer Virus Program of the Frederick National Laboratory for Cancer Research have used a novel vaccine approach to achieve a “functional cure” and apparent eradication of infection with a monkey version of the AIDS virus.

Partnership to Explore New Drug Combination for Pancreatic Cancer

Scientists at NCI and Frederick National Laboratory for Cancer Research (FNLCR) are partnering with the Lustgarten Foundation to test whether a vitamin D derivative will make a difference when combined with a conventional anticancer drug in treating tumors of the pancreas.